Related Experiment Video
Updated: Jul 10, 2025

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Fibrinogen B β promoter polymorphism may not be associated with pulmonary embolism
Wenxiang Chen1, Shengbin Han1, Jingzhe Xu1
1Department of Vascular Surgery, The First Affiliated Hospital, Kunming Medical University, Kunming, China.
Objective:
A prospective experiment was designed to explore all possible SNPs in the promoter region of fibrinogen B β (FGB) and reveal the influence of these SNPs on susceptibility of pulmonary embolism.
Methods:
In this 2-year randomized prospective study, we had totally recruited 203 volunteers. 58 PE patients (58 out of 145 VTE patients) and 114 healthy people were taken as case and control objects, respectively. FGB promoter was detected by gene sequencing.
Results:
There were 6 SNPs in FGB promoter, which were β-1420G/A, β-993C/T, β-854G/A, β-455G/A, β-249C/T, and β-148C/T. Genotype frequencies of individual SNPs between the cases and controls were not statistically significant, all p > .05. After excluding subjects of COVID-19 infection within 6 months, the statistical results (35 PE patients vs 66 healthy people) were consistent.
Conclusion:
The susceptibility to pulmonary embolism may not be affected by any SNP in the FGB promoter region.
Related Concept Videos
Pulmonary Embolism I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pulmonary Embolism III: Nursing Management
Venous Thrombosis I: Introduction

